Prazosin

Prazosin is an alpha-blocker that blocks a chemical in the body, causing blood vessels and the muscles around the urethra to relax.

Product dosage: 5mg
Package (num)	Per pill	Price	Buy
30	$2.90	$87.00 (0%)	🛒 Add to cart
60	$2.43	$174.00 $146.00 (16%)	🛒 Add to cart
90	$2.28	$261.00 $205.00 (21%)	🛒 Add to cart
120	$2.20	$348.00 $264.00 (24%)	🛒 Add to cart
180	$2.12	$522.00 $381.00 (27%)	🛒 Add to cart
270	$2.07	$783.00 $558.00 (29%)	🛒 Add to cart
360	$2.05 Best per pill	$1044.00 $737.00 (29%)	🛒 Add to cart
Synonyms Hypovase Minizide Prazopress Prazosinum

Prazosin hydrochloride is a selective alpha-1 adrenergic receptor antagonist, a quinazoline derivative prescribed primarily for the management of hypertension. Its unique mechanism of action, blocking postsynaptic alpha-1 adrenoreceptors on vascular smooth muscle, leads to vasodilation and a subsequent reduction in peripheral vascular resistance. Beyond its cardiovascular indications, prazosin has gained significant recognition and off-label use for its profound efficacy in mitigating trauma-associated nightmares and sleep disturbances in patients with Post-Traumatic Stress Disorder (PTSD). This dual therapeutic profile makes it a versatile agent in both cardiology and psychiatry, offering a targeted approach to two distinct yet debilitating conditions.

Features

• Selective alpha-1 adrenergic receptor antagonist
• Available in oral tablet formulations (1mg, 2mg, 5mg)
• Generic and brand-name versions (Minipress)
• Primarily metabolized hepatically via demethylation and conjugation
• Onset of antihypertensive effect occurs within two hours; peak effect at two to three hours
• Demonstrated high affinity for alpha-1 receptors in the brain and vascular smooth muscle

Benefits

• Effectively lowers both systolic and diastolic blood pressure by reducing peripheral vascular resistance.
• Significantly reduces the frequency and intensity of trauma-related nightmares and improves sleep quality in patients with PTSD.
• Does not typically cause significant reflex tachycardia due to its selective alpha-1 blockade, sparing beta-adrenergic receptors.
• May improve benign prostatic hyperplasia (BPH) symptoms by relaxing smooth muscle in the bladder neck and prostate.
• Can be used as part of a combination antihypertensive regimen for synergistic effects.
• Offers a non-habit-forming, non-sedative-hypnotic option for addressing sleep disturbances.

Common use

Prazosin is most commonly prescribed for the treatment of hypertension, either as monotherapy or, more frequently, in combination with a diuretic or other antihypertensive agents. Its second most prevalent use, though officially off-label, is for the management of nightmare disorder associated with PTSD. It is also used off-label for the treatment of Raynaud’s phenomenon, for the symptomatic relief of urinary obstruction in benign prostatic hyperplasia (BPH), and for the treatment of complex regional pain syndrome. Its utility in these diverse conditions stems from its ability to antagonize alpha-1 receptors in vascular smooth muscle and within the central nervous system.

Dosage and direction

For hypertension, the initial adult dosage is 1 mg two or three times daily. The maintenance dose may be slowly increased to a total daily dose of 20 mg given in divided doses, though the effective dosage range is typically 6 mg to 15 mg daily. Doses exceeding 20 mg daily usually do not increase efficacy. For PTSD-associated nightmares, dosing is highly individualized. Treatment often begins with a very low dose of 1 mg at bedtime to assess tolerance, particularly to first-dose hypotension. The dose can be gradually titrated upward based on therapeutic response and side effects, with many patients finding benefit between 3 mg and 15 mg at bedtime. Doses for other off-label uses vary. The drug may be taken with or without food; however, consistency is advised. Patients must be instructed to take the first dose at bedtime due to the risk of significant first-dose syncope (fainting).

Precautions

Patients should be cautioned about the potential for first-dose syncope, a sudden loss of consciousness due to a profound drop in blood pressure, particularly after the initial dose or a rapid dosage increase. This risk is higher in patients who are volume-depleted or salt-restricted. Orthostatic hypotension (a drop in blood pressure upon standing) can occur, especially during dosage initiation and titration. Patients should be advised to rise slowly from a sitting or lying position. Use with caution in patients with impaired liver function, as the drug is extensively metabolized by the liver. Prazosin may cause drowsiness or dizziness, which can impair mental and physical abilities required for tasks such as driving or operating machinery. Intraoperative floppy iris syndrome has been observed during cataract surgery in patients on or previously treated with alpha-1 blockers.

Contraindications

Prazosin is contraindicated in patients with a known hypersensitivity to prazosin, any other quinazolines (e.g., doxazosin, terazosin), or any component of the formulation. Its use is also contraindicated in the context of hypotensive shock or profoundly low blood pressure.

Possible side effect

The most common side effects are related to its pharmacological action and are often dose-dependent. These include:

• Dizziness (10.3%)
• Drowsiness (7.6%)
• Headache (7.8%)
• Lack of energy (6.9%)
• Weakness (6.5%)
• Palpitations (5.3%)
• Nausea (4.9%) Less common but more serious side effects can include:
• Syncope (first-dose effect, ~1%)
• Pronounced orthostatic hypotension
• Priapism (a prolonged and painful erection; requires immediate medical attention)
• Blurred vision
• Edema

Drug interaction

Prazosin can have significant interactions with other medications that affect blood pressure or are metabolized through similar pathways.

• Other Antihypertensives (Beta-blockers, Diuretics, ACE Inhibitors, Calcium Channel Blockers): Concomitant use can potentiate the hypotensive effects of prazosin, increasing the risk of syncope and orthostasis.
• Phosphodiesterase-5 Inhibitors (e.g., Sildenafil, Tadalafil): Concurrent use can cause a severe additive drop in blood pressure; this combination is not recommended.
• CNS Depressants (e.g., Alcohol, Benzodiazepines, Opioids): May potentiate the sedative and dizziness effects of prazosin.
• Non-Steroidal Anti-Inflammatory Drugs (NSAIDs): May attenuate the antihypertensive effect of prazosin by causing fluid retention.
• Strong CYP3A4 Inhibitors (e.g., Ketoconazole, Itraconazole): May increase prazosin plasma concentrations, increasing the risk of adverse effects.

Missed dose

If a dose is missed, it should be taken as soon as it is remembered. However, if it is almost time for the next scheduled dose, the missed dose should be skipped, and the regular dosing schedule resumed. Patients should never take a double dose to make up for a missed one, as this significantly increases the risk of hypotension and syncope.

Overdose

Symptoms of a prazosin overdose are primarily an extension of its adverse effects and can be severe. They include profound hypotension, dizziness, drowsiness, shock, and syncope. Bradycardia (slow heart rate) may also occur. In the event of a suspected overdose, emergency medical attention must be sought immediately. Treatment is primarily supportive and symptomatic, focusing on stabilizing cardiovascular function. This may involve placing the patient in a supine position with legs elevated to manage hypotension. Volume expansion with intravenous fluids is a first-line treatment. Vasopressors may be required for refractory hypotension, but caution is advised as the patient’s vascular system is already alpha-1 blocked.

Storage

Prazosin tablets should be stored at room temperature, between 20°C to 25°C (68°F to 77°F), in a tightly closed container. The medication must be kept away from light, excess moisture, and heat. It should always be stored out of reach and sight of children and pets. Do not store in bathrooms or other damp places. Unused medication should be disposed of via a official medicine take-back program.

Disclaimer

This information is for educational and informational purposes only and does not constitute medical advice. It is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition or before starting, stopping, or changing any prescribed part of your care plan. Never disregard professional medical advice or delay in seeking it because of something you have read here.

Reviews

• Clinical Consensus: Prazosin is widely regarded by cardiologists as a well-established, effective second-line agent for hypertension, particularly useful in combination regimens. Its selectivity offers a favorable side effect profile compared to non-selective alpha-blockers.
• Psychiatric Application: Among psychiatrists specializing in trauma, prazosin is often described as a “game-changer” for a subset of PTSD patients. Numerous clinical studies and extensive anecdotal evidence report dramatic reductions in nightmare frequency and severity, leading to significantly improved sleep and daytime functioning. The response is not universal, but for responders, the benefit is substantial.
• Patient Feedback: Patient reviews are often bifurcated. Those taking it for hypertension frequently comment on its effectiveness but note the initial dizziness. Patients with PTSD who respond well to the drug for nightmares provide overwhelmingly positive testimonials, describing it as life-altering, allowing for the first restful sleep in years. A common thread is the emphasis on the importance of slow titration to mitigate side effects.